Litican 50 mg/2 ml inj. sol. i.m./i.v. amp.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Alizapride Hydrochloride 55,8 mg/2 ml - Eq. Alizapride 50 mg/2 ml
Available from:
Sanofi Belgium SA-NV
ATC code:
A03FA05
INN (International Name):
Alizapride Hydrochloride
Dosage:
50 mg/2 ml
Pharmaceutical form:
Solution for injection
Composition:
Alizapride Hydrochloride
Administration route:
Intramuscular use; Intravenous use
Therapeutic area:
Alizapride
Product summary:
CTI code: 122823-01 - Pack size: 6 x 2 ml - Commercialisation status: YES - FMD code: 03582910086925 - CNK code: 0818724 - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
1983-04-27
